COMPANY

ProKidney

15 open jobs · last seen Oct 23, 2026 · 10 sources

Keywords: cell therapy renal chronic kidney disease kidney failure Diabetic Kidney Disease Chronic Kidney Diseases Type 2 Diabetes Mellitus Type 1 Diabetes Mellitus Congenital Anomalies of Kidney and Urinary Tract Type 2 Diabetes Renal Autologous Cell Therapy Renal Autologous Cell Therapy (REACT/ rilparencel) Neo-Kidney Augment

Profile checked Oct 10, 2026

15Open jobs 10Trials (company is sponsor)

Hiring

Title	Location (from posting)	Employer posted	First seen
Quality Assurance Specialist 2, Batch Release Contractor	Winston-Salem, North Carolina, United States	Oct 21, 2026	Oct 22, 2026
Quality Assurance Specialist 1, Batch Release Contractor	Winston-Salem, North Carolina, United States	Oct 21, 2026	Oct 22, 2026
Manufacturing Cell Processing Specialist 1 Contractor	Winston-Salem, North Carolina, United States	Oct 13, 2026	Oct 21, 2026
Manufacturing Support Specialist 1 Contractor	Winston-Salem, North Carolina, United States	Oct 5, 2026	Oct 21, 2026
Associate Director, IT GxP & Quality Systems	Winston-Salem, North Carolina, United States	Sep 29, 2026	Oct 21, 2026

See all 15 jobs

Timeline

Jul 17, 2024 Trial start Phase 3: A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease source ↗
Dec 11, 2023 Trial start —: A Long-Term Follow-Up Study of Participants Exposed to REACT source ↗
Nov 23, 2023 Trial start —: Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product source ↗
Jul 11, 2023 Trial start Phase 1: A Study of Participants With Chronic Kidney Disease Previously Treated With REACT source ↗
Jan 5, 2022 Trial start Phase 3: Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease source ↗
Jul 27, 2021 Trial start Phase 2: Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007) source ↗
Aug 13, 2019 Trial start Phase 1: A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). source ↗
Apr 25, 2018 Trial start Phase 2: A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease source ↗
2016-09 Trial start Phase 2: A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease source ↗
2016-07 Trial start Phase 2: Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) source ↗

Upcoming milestones

2028-01 (ESTIMATED) · · A Long-Term Follow-Up Study of Participants Exposed to REACT · NCT05918523
2029-12 (ESTIMATED) · Phase 3 · Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease · NCT05099770
May 31, 2030 (ESTIMATED) · · Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product · NCT06790498

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 10

Record	Title	Phase	Status	Start	Primary completion
NCT06790498	Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product	Not listed	Enrolling by invitation	Nov 23, 2023	May 31, 2030 (estimated)
NCT05918523	A Long-Term Follow-Up Study of Participants Exposed to REACT	Not listed	Recruiting	Dec 11, 2023	2028-01 (estimated)
NCT05099770	Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Phase 3	Active, not recruiting	Jan 5, 2022	2029-12 (estimated)
NCT05018416	Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)	Phase 2	Completed	Jul 27, 2021	May 20, 2025 (actual)
NCT02836574	A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease	Phase 2	Completed	2016-09	2023-12 (actual)
NCT03270956	A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease	Phase 2	Completed	Apr 25, 2018	Nov 17, 2022 (actual)
NCT05694169	A Study of Participants With Chronic Kidney Disease Previously Treated With REACT	Phase 1	Terminated	Jul 11, 2023	Mar 19, 2024 (actual)
NCT05286853	A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease	Phase 3	Withdrawn	Jul 17, 2024	Sep 3, 2024 (actual)
NCT04115345	A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).	Phase 1	Completed	Aug 13, 2019	Jan 31, 2023 (actual)
NCT02525263	Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)	Phase 2	Terminated	2016-07	2017-05 (actual)

Open jobs 15

Title	Location (from posting, not HQ)	Employer posted	First seen	Level
Quality Assurance Specialist 2, Batch Release Contractor	Winston-Salem, North Carolina, United States	Oct 21, 2026	Oct 22, 2026	Not stated
Quality Assurance Specialist 1, Batch Release Contractor	Winston-Salem, North Carolina, United States	Oct 21, 2026	Oct 22, 2026	Not stated
Manufacturing Cell Processing Specialist 1 Contractor	Winston-Salem, North Carolina, United States	Oct 13, 2026	Oct 21, 2026	Not stated
Manufacturing Support Specialist 1 Contractor	Winston-Salem, North Carolina, United States	Oct 5, 2026	Oct 21, 2026	Not stated
Associate Director, IT GxP & Quality Systems	Winston-Salem, North Carolina, United States	Sep 29, 2026	Oct 21, 2026	Not stated
Material Handler 1 Contractor	Winston-Salem, North Carolina, United States	Sep 28, 2026	Oct 21, 2026	Not stated
Director of Sterility Assurance	Winston-Salem, North Carolina, United States	Sep 28, 2026	Oct 21, 2026	Not stated
Associate Director, Raw Materials MSAT	Winston-Salem, North Carolina, United States	Sep 28, 2026	Oct 21, 2026	Not stated
Director, CMC Project Management	Remote; Winston-Salem, North Carolina, United States	Sep 10, 2026	Oct 21, 2026	Not stated
Quality Assurance Specialist 2, Floor Support	Winston-Salem, North Carolina, United States	Sep 4, 2026	Oct 21, 2026	Not stated
Senior Manager, Validation	Winston-Salem, North Carolina, United States	Sep 1, 2026	Oct 21, 2026	Not stated
Statistical Programming Contractor	Remote	Aug 20, 2026	Oct 21, 2026	Not stated
Sr. Director, Biostatistics	Remote	Aug 19, 2026	Oct 21, 2026	Not stated
Associate Director, Validation	Winston-Salem, North Carolina, United States	Mar 12, 2026	Oct 21, 2026	Not stated
Sr. Director, Quality Operations	Winston-Salem, North Carolina, United States	Feb 2, 2026	Oct 21, 2026	Not stated

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.